TG Therapeutics
TGTX
TGTX
101 hedge funds and large institutions have $422M invested in TG Therapeutics in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 35 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
5% less funds holding
Funds holding: 106 → 101 (-5)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Holders
101
Holding in Top 10
2
Calls
$9.23M
Puts
$5.16M
Top Buyers
| 1 | +$7.7M | |
| 2 | +$7.27M | |
| 3 | +$2.56M | |
| 4 |
Charles Schwab
San Francisco,
California
|
+$1.84M |
| 5 |
CCI
Columbus Circle Investors
|
+$1.62M |
Top Sellers
| 1 | -$2.13M | |
| 2 | -$1.71M | |
| 3 | -$1.27M | |
| 4 |
SAM
Senzar Asset Management
New York
|
-$1.25M |
| 5 |
AG
Artal Group
Luxembourg
|
-$1.19M |